Comparison

Best Quant Investing Tools in India (2026): Research, Backtesting and Execution Compared

The best quant tool in India depends on whether you need stock screening, fundamental backtesting, portfolio construction or broker execution. Here is a fair comparison.

#best-quant-tools-india#quantitative-investing#stock-screeners#backtesting#portfolio-governance
Best Quant Investing Tools in India (2026): Research, Backtesting and Execution Compared

The best quant investing tool in India depends on the job. Screener.in is a strong starting point for fundamental screening and Excel models; Trendlyne adds broad screeners, historical tests, estimates and alerts; Streak focuses on systematic trading; smallcase focuses on investable baskets; and Altys is built for rule-based research and portfolio governance at PMS, AIF and family-office desks. These products overlap, but they are not interchangeable.

This is a vendor-authored comparison. Altys is included, so the useful standard is transparency: every competitor below gets a real use case it suits, every claim links to public product material, and no platform is declared universally best.

First, separate four jobs that search results mix together

A search for “best quant tools in India” often returns algo trading software, options backtesters, stock screeners and portfolio products in one list. That is like comparing a research terminal with a broker because both display prices.

The category contains four different jobs:

  1. Screening and research: define financial or market conditions and find matching companies.
  2. Backtesting: replay a fully specified rule on historical data.
  3. Portfolio construction: turn scores into holdings, weights, caps and a rebalance schedule.
  4. Execution: translate the portfolio or trading signal into broker orders.

Some tools cover more than one job. None should be evaluated as if all four are the same.

The shortlist at a glance

ToolMain jobRules and testsResearch depthVerification and outputBest fit
Screener.inFundamental company analysis and screeningCustom queries and ratios; automatic screen alertsLong-run financials, segments, filings, announcements and company comparisonStructured Excel export and user-defined Excel templatesIndividual fundamental investors and spreadsheet model builders
TrendlyneBroad market analytics and screeningAI and conventional screeners, DVM scores, screener backtests and alertsFinancials, technicals, estimates, portfolios, calls and market dashboardsData download and Excel Connect on eligible plansActive investors wanting many signals and alerts in one product
Tijori FinanceCompany, sector and operating-data researchNatural-language stock screener plus tracking and alertsOperational metrics, revenue mix, market share, raw materials, macro and source linksWeb research and downloadable data where offeredFundamental investors who care about the business behind reported totals
StreakSystematic tradingStrategy builder, scanners and backtestsPrimarily price, technical and trading conditionsBroker-connected trading workflow for Zerodha usersTraders automating explicit entry and exit logic
smallcasePortfolio baskets and executionReady-made portfolios and user-created baskets; manager-led rebalance updatesPortfolio and product context rather than deep company diligenceHoldings through an existing broker accountInvestors who want a portfolio they can hold and rebalance easily
AltysRule-based investment research and governanceScreens, factor scorecards, period-correct backtests and monitoring rules on one research recordFinancials, filings, concalls, guidance, ownership, factors, macro and mutual fundsSource-linked evidence plus Excel-verifiable outputsPMS, AIF, family-office and research teams managing Indian books

The table describes public product focus as of September 2026. Features and commercial terms change, so test the current product on your own workflow before buying.

Best starting point for fundamental screening: Screener.in

Screener.in is usually the cleanest starting point for an Indian investor who wants to filter companies on reported numbers. Its public feature page highlights 10 to 15 years of financial data, custom ratios, automatic screen alerts, segment results, filing tracking and structured Excel exports.

That combination is genuinely useful. You can create a rule such as minimum sales growth, return on capital and interest coverage, review the shortlist, then export the statements into a model you understand.

The important boundary is scope. Screening is one stage of a quantitative process. A professional portfolio rule also needs an as-of universe, position sizing, rebalance timing, transaction assumptions, version control and a record of exceptions. If your need stops at finding and studying companies, adding institutional machinery would be unnecessary.

Best broad retail analytics suite: Trendlyne

Trendlyne covers a wider collection of market jobs. Its official material lists conventional and AI-assisted screeners, DVM scores, historical screener tests, analyst estimates, portfolio analytics, company reports and alerts. Eligible plans also provide bulk data downloads and Excel Connect.

That makes it a practical fit for investors who want to scan, compare, follow consensus and receive frequent alerts without assembling several tools.

One backtest detail is especially useful because Trendlyne documents it openly: its help page says an index backtest applies the current constituents through the test rather than reconstructing historical membership. That does not make the feature useless. It means the result answers a narrower question and should not be mistaken for a survivorship-free institutional simulation. This is exactly the kind of methodology disclosure every buyer should look for.

Best for operating context: Tijori Finance

Tijori Finance is strongest when the question is not only “which ratio changed?” but “what does this company actually sell, and what moved underneath the reported number?” Its public pages describe company and sector research, operating metrics, revenue mix, market share, raw-material tracking, macro indicators, source links, a stock screener, portfolio tracking and alerts.

That depth matters because two companies can report identical revenue growth for completely different reasons. Price, volume, mix, acquisition and currency do not deserve the same interpretation.

Tijori’s centre of gravity is research and context. An investor who needs portfolio-level rule versioning, a period-correct fundamental simulation or committee records should test those needs separately rather than assuming every research portal covers them.

Best for broker-linked systematic trading: Streak

Streak is a different product category. It is built around scanners, rule-based equity and options strategies, backtesting and a workflow for Zerodha users. If the problem is converting technical conditions into repeatable trading actions, this is more relevant than a fundamental research terminal.

The distinction matters because a trading backtest and a fundamental portfolio backtest fail differently. A trading test is highly sensitive to fills, slippage, latency and intraday data. A fundamental test is highly sensitive to when financial information became public, historical universe membership, restatements and rebalance timing. Do not select one engine by reading the checklist for the other.

Best for holding and rebalancing baskets: smallcase

smallcase gives investors access to ready-made portfolios of stocks, ETFs and mutual funds managed by registered experts, and it also lets users create their own baskets. Holdings sit through an existing broker account, while rebalance updates help keep a subscribed portfolio aligned with its stated idea.

That is valuable if your bottleneck is implementation. The research rule may belong to the portfolio manager rather than to you, but the operational path from a portfolio idea to real holdings is short.

A research desk has a different bottleneck. It needs to prove why the rule exists, which evidence supported each holding, what was known on the approval date and what later changed. Basket execution does not automatically create that record.

Best fit for rule-based research governance: Altys

Altys is built for Indian investment teams that already have an investment process and want to make it reproducible. The process can combine quantitative and qualitative work:

  • define an eligible universe and hard exclusion gates;
  • create factor scorecards using the firm’s own weights and formulas;
  • seal a version and replay it on data that was knowable at each past date;
  • investigate shortlisted companies using filings, concalls, management guidance, ownership and operating evidence;
  • record human exceptions instead of letting them disappear into memory;
  • connect approved holdings to monitoring conditions and alerts;
  • export important calculations and outputs to Excel for independent inspection.

Altys does not place trades and does not generate stock tips. Its job is to keep discovery, evaluation, diligence, monitoring and review on the same source-linked research record. That is why the relevant comparison is not “which app has more ratios?” It is “can the whole investment process be reproduced later?”

Read why India needs rule-based portfolio governance for the broader thesis and how Altys approaches financial AI reliability for the calculation and evidence boundary.

Seven checks before trusting any quant platform

1. What did the model know on the decision date?

For any fundamental rule, ask whether a March-year-end number enters the test on 31 March or only after the result was filed. The first choice quietly gives the strategy future information.

2. Is the historical universe real?

A test on today’s Nifty or NSE constituents excludes many companies that disappeared, merged or were removed. That is survivorship bias. Ask whether membership is reconstructed date by date.

3. Are formulas defined?

“Quality” is not a factor definition. A reproducible score specifies the inputs, the reporting basis, the treatment of missing data, the peer group, the ranking method and the weight.

4. Are costs and liquidity inside the test?

Turnover, brokerage, taxes, spread and impact can turn an attractive gross simulation into an ordinary implementable one. Small-cap strategies need a capacity rule, not only a return curve.

5. Can a sealed version be rerun?

If changing a factor silently rewrites old results, there is no audit trail. Each meaningful rule change should create a new version while the old output remains reproducible.

6. What happens when data is absent?

Missing is not zero. A company without a usable cash-flow observation should not automatically receive the score for zero cash flow. The platform should expose absence and its reason.

7. Can you verify the result outside the product?

An export is useful only if it lets you inspect the input values, formulas, dates and rule version. A screenshot of a score is not verification. A formula-bearing workbook or documented calculation chain is.

The practical answer

For many individual investors, Screener.in plus Excel is enough. Add Trendlyne when broad signals, estimates and alerts are the priority; Tijori Finance when operating context matters; Streak when the job is systematic trading; and smallcase when easy portfolio implementation matters.

For a PMS, AIF or family office, the selection question changes. The best fit is the system that can preserve the firm’s own rules, replay them honestly, join the shortlist to qualitative evidence, record exceptions, watch the live book and reproduce the decision later. That is the rule-based governance problem Altys is designed to solve.

This article compares research and investing software, not securities. It is educational and does not contain investment advice or a recommendation. Altys Labs publishes this page and is one of the products discussed. Altys is not a broker or a SEBI-registered Research Analyst or Investment Adviser.

Frequently asked questions

Which is the best quant investing tool in India?

For fundamental screening and Excel models, Screener.in is a strong starting point. Trendlyne suits investors who want large screener libraries, estimates, historical screener tests and alerts. Streak is aimed at systematic trading and broker-linked execution. smallcase is useful for holding and rebalancing baskets. Altys is built for PMS, AIF and family-office teams that need point-in-time fundamental research, versioned rules, backtests, qualitative evidence and monitoring on one audit trail.

Is a quant investing tool the same as an algo trading platform?

No. A quant investing tool helps define and test a rule for selecting, weighting and reviewing investments. An algo trading platform automates how orders are generated or executed. A quarterly fundamental portfolio can be quantitative without automated trading, while a discretionary trade can use algorithmic execution.

Can Screener.in be used for quantitative investing?

Yes. Screener.in supports custom queries and ratios over long-run Indian company financials, automatic screen alerts and structured Excel exports. It is useful for idea generation and model building. A complete institutional process may additionally require period-correct fundamental backtests, versioned scorecards, portfolio rules and a permanent decision record.

What should a PMS or AIF check before buying a quant research platform?

Check whether financial history is point-in-time, whether past universes can be reconstructed, how corporate actions, liquidity and costs are handled, whether every factor is defined, whether scorecard versions remain reproducible, whether qualitative vetoes are recorded, and whether outputs can be independently inspected in Excel or code.

Does quantitative investing remove human judgement?

No. It moves judgement into the design of the universe, factors, weights, risk limits and review rules. Human judgement is still needed for evidence a model does not capture and for deciding when a rule no longer describes the world. The useful discipline is to write down where rules end and discretion begins.